Results 111 to 120 of about 5,745,790 (267)

Isolation of circulating tumor cells in a preclinical model of osteosarcoma: Effect of chemotherapy

Journal of Bone Oncology, 2018
Osteosarcoma is a rare primary bone tumor, which mainly affects children and adolescents and has a poor prognosis, especially for patients with metastatic disease.
Antoine Chalopin, Marta Tellez-Gabriel, Hannah K. Brown, François Vallette, Marie-Françoise Heymann, Francois Gouin, Dominique Heymann   +6 more
doaj   +1 more source

The isolation and characterization of circulating tumor cells from head and neck cancer patient blood samples using spiral microfluidic technology

, 2019
Metastasis is responsible for 90% of cancer-related deaths. The study of circulating tumor cells (CTCs) enables the study of the units of disease responsible for the process of metastasis.
Chamindie Punyadeera, Warkiani, Majid Ebrahimi, Punyadeera, Chamindie, Majid Ebrahimi Warkiani, Kulasinghe, Arutha, Kulasinghe, A, Warkiani, ME, Arutha Kulasinghe, Punyadeera, C   +8 more
core   +1 more source

Ovarian Cancer: Epidemiology, Disease Mechanisms, New Diagnosis and Treatment Strategies, and Research Directions

iNew Medicine, EarlyView.
ABSTRACT Ovarian cancer (OC) continues to be the deadliest gynecological malignancy and a significant cause of cancer‐related mortality among women worldwide. Standard treatment strategies typically entail platinum‐based chemotherapy in conjunction with cytoreductive surgery.
Zunera Khalid, Weirong Fan, Farah Nazir, Yixiang Xing, Tengchuan Jin   +4 more
wiley   +1 more source

Detection of the circulating tumor cells in cancer patients

, 2010
As the presence of tumor cells circulating in the blood is associated with systemic disease and shortened survival, the establishment of a method to detect circulating tumor cells (CTCs) is of critical importance for a more concise staging and follow-up ...
Lembessis, P., Nezos, A., Tsouma, A., Koutsilieris, M., Pissimissis, N., Armakolas, A., Panteleakou, Z., Skondra, M.   +7 more
core   +2 more sources

HER2-positive circulating tumor cells in breast cancer.

, 2011
Circulating Tumor Cells (CTCs) detection and phenotyping are currently evaluated in Breast Cancer (BC). Tumor cell dissemination has been suggested to occur early in BC progression.
Ignatiadis, Michail, Carmen Criscitiello, Sotiriou, Christos, Frédéric Buxant, Ghizlane Rouas, Piccart-Gebhart, Martine, Sandeep K. Singhal, Denis Larsimont, Criscitiello, Carmen, Liebens, Fabienne, Isabelle Veys, Chaboteaux, Carole, Silvia Bessi, Bessi, Silvia, Stefan Michiels, Birgit Carly, Michiels, Stefan, Kheddoumi, Naima, Virginie Durbecq, Buxant, Frédéric, Françoise Rothé, Carly, Birgit, Rouas, Ghizlane, Naima Kheddoumi, Durbecq, Virginie, Marta Pestrin, Fabienne Liebens, Singhal, Sandeep K, Jessica Metallo, Sandeep K Singhal, José Rossari, Rothé, Françoise, Carole Chaboteaux, Christos Sotiriou, Martine Piccart, Michail Ignatiadis, Larsimont, Denis, Pestrin, Marta, Veys, Isabelle, Metallo, Jessica, Rossari, José, Rouas Ghizlane, Veys Isabelle, Sotiriou Christos, Ignatiadis Michail, Liebens Fabienne, Bessi Silvia, Pestrin Marta, Piccart Martine, Kheddoumi Naima, Durbecq Virginie, Carly Birgit, Chaboteaux Carole, Rothé Françoise, Larsimont Denis, Metallo Jessica, Buxant Frédéric, Criscitiello Carmen, Singhal Sandeep K., Rossari José, Michiels Stefan   +60 more
core   +1 more source

Liquid biopsy across cancers: Integrating circulating biomarkers, tumor biology, artificial intelligence, and clinical translation

Interdisciplinary Medicine, EarlyView.
Liquid biopsy uses non‐invasive sampling of blood or body fluids to isolate circulating analytes, including circulating tumor DNA, circulating tumor cells, extracellular vesicles, and RNA. These are analyzed using next‐generation sequencing, qPCR, and proteomics to inform cancer detection, monitoring, and characterization. Figure created with BioRender.
Jaswinder Singh, Manjeet Kumar, Kajal Kamra   +2 more
wiley   +1 more source

Deterministic separation of cancer cells from blood at 10 mL/min

AIP Advances, 2012
Circulating tumor cells (CTCs) and circulating clusters of cancer and stromal cells have been identified in the blood of patients with malignant cancer and can be used as a diagnostic for disease severity, assess the efficacy of different treatment ...
Kevin Loutherback, Joseph D'Silva, Liyu Liu, Amy Wu, Robert H. Austin, James C. Sturm   +5 more
doaj   +1 more source

Prognostic value of pre- and post-operative circulating tumor cells detection in colorectal cancer patients treated with curative resection: a prospective cohort study based on ISET device

, 2018
Chaogang Yang,1–3,* Dongdong Shi,1–3,* Shuyi Wang,1–3 Chen Wei,1–3 Chunxiao Zhang,1–3 Bin Xiong1–3 1Department of Gastrointestinal Surgery and Department of Gastric and Colorectal Surgical Oncology, Zhongnan Hospital ...
Wang S, Wei C, Xiong B, Shi D, Zhang C, Yang C   +5 more
core  

Radiomics and circulating tumor cells: personalized care in hepatocellular carcinoma? [PDF]

, 2015
Personalized care in oncology is expected to significantly improve morbidity and mortality, facilitated by our increasing understanding of the molecular mechanisms driving tumors and the ability to target those drivers.
Richard L. Hesketh, Andrew X. Zhu, Rahmi Oklu   +2 more
core   +1 more source

Interleukin‐37 Enhances Liver NK Cell Cytotoxicity and Improves Recurrence‐Free Survival in Hepatocellular Carcinoma Patients

Journal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
ABSTRACT Introduction Hepatocellular carcinoma (HCC) remains a major cause of cancer‐related mortality worldwide, and postoperative recurrence continues to limit long‐term survival. Liver‐resident natural killer (NK) cells are key effectors of antitumor immunity in the hepatic microenvironment. Interleukin‐37 (IL‐37), an anti‐inflammatory cytokine, has
Yuki Imaoka, Masahiro Ohira, Yuka Tanaka, Toshihiro Nakayama, Miho Akabane, Shinichiro Yokota, Sheri M. Krams, Olivia M. Martinez, Carlos O. Esquivel, Kazunari Sasaki, Hideki Ohdan   +10 more
wiley   +1 more source